Douglas J. Swirsky
2019
In 2019, Douglas J. Swirsky earned a total compensation of $650.7K as Former President and Chief Executive Officer at Rexahn Pharmaceuticals, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,500 |
|---|---|
| Salary | $425,000 |
| Other | $13,177 |
| Total | $650,677 |
Swirsky received $425K in salary, accounting for 65% of the total pay in 2019.
Swirsky also received $212.5K in non-equity incentive plan and $13.2K in other compensation.
Rankings
In 2019, Douglas J. Swirsky's compensation ranked 10,962nd out of 13,971 executives tracked by ExecPay. In other words, Swirsky earned more than 21.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,962 out of 13,971 | 22nd |
Division Manufacturing | 4,435 out of 5,701 | 22nd |
Major group Chemicals And Allied Products | 1,738 out of 2,200 | 21st |
Industry group Drugs | 1,492 out of 1,886 | 21st |
Industry Pharmaceutical Preparations | 1,103 out of 1,398 | 21st |
Source: SEC filing on April 26, 2021.